Pfizer cashes in on pandemic: Pharma giant plans to sell its vaccine with a 10,000% markup – despite revenues tripling and CEO pocketing $50m… Biden: Not enough people are getting [vaccinated.]

Pfizer plans to price its COVID-19 vaccine at $130 each when it hits the public market next year

This is a markup of over 10,000% compared to the estimated $1.18 it costs for the firm to develop the shot

While the firm did not receive US tax payer funds, its partner BioNTech took public money from Germany

We are primarily funded by readers. Please subscribe and donate to support us!

The firm’s yearly revenue has more than doubled from 2019 to a projection of over $100billion this year


Not enough people are getting [vaccinated.] We’ve got to change that, so we can all have a safe and healthy holiday season.



Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.